224 related articles for article (PubMed ID: 28825961)
1. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering.
Wang C; Hu S; Sun CC
Mol Pharm; 2017 Oct; 14(10):3399-3408. PubMed ID: 28825961
[TBL] [Abstract][Full Text] [Related]
2. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach.
Wang C; Sun CC
Int J Pharm; 2020 Nov; 589():119816. PubMed ID: 32877727
[TBL] [Abstract][Full Text] [Related]
3. Expedited development of a high dose orally disintegrating metformin tablet enabled by sweet salt formation with acesulfame.
Wang C; Hu S; Sun CC
Int J Pharm; 2017 Oct; 532(1):435-443. PubMed ID: 28844896
[TBL] [Abstract][Full Text] [Related]
4. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
5. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
6. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
10. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
Rahman Z; Siddiqui A; Khan MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
Ge Z; Yang M; Wang Y; Shan L; Gao C
Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
13. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
Tafere C; Yilma Z; Abrha S; Yehualaw A
PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
[TBL] [Abstract][Full Text] [Related]
14. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet.
Liew KB; Peh KK
Arch Pharm Res; 2021 Aug; 44(8):1-10. PubMed ID: 25579848
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
Sheshala R; Khan N; Chitneni M; Darwis Y
Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
[TBL] [Abstract][Full Text] [Related]
16. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
17. Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process.
Elnaggar YS; El-Massik MA; Abdallah OY; Ebian AE
AAPS PharmSciTech; 2010 Jun; 11(2):645-51. PubMed ID: 20405257
[TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
19. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering.
Perumalla SR; Sun CC
J Pharm Sci; 2014 Apr; 103(4):1126-32. PubMed ID: 24515970
[TBL] [Abstract][Full Text] [Related]
20. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]